Chang S, Rosenberg M J, Morton H, Francomano C A, Biesecker L G
Laboratory of Genetic Disease Research and Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Hum Mol Genet. 1998 May;7(5):865-70. doi: 10.1093/hmg/7.5.865.
Glycogen storage disease type VI (GSD6) defines a group of disorders that cause hepatomegaly and hypoglycemia with reduced liver phosphorylase activity. The course of these disorders is generally mild, but definitive diagnosis requires invasive procedures. We analyzed a Mennonite kindred with an autosomal recessive form of GSD6 to determine the molecular defect and develop a non-invasive diagnostic test. Linkage analysis was performed using genetic markers flanking the liver glycogen phosphorylase gene ( PYGL ), which was suspected to be the cause of the disorder on biochemical grounds. Mennonite GSD6 was linked to the PYGL locus with a multipoint LOD score of 4.7. The PYGL gene was analyzed for mutations by sequencing genomic DNA. Sequencing of genomic DNA revealed a splice site abnormality of the intron 13 splice donor. Confirmation of the genomic mutation was performed by sequencing RT-PCR products, which showed heterogeneous PYGL mRNA lacking all or part of exon 13 in affected persons. This study is the first to demonstrate that a mutation in the PYGL gene can cause GSD6. This mutation is estimated to be present on 3% of Mennonite chromosomes and the disease affects 0.1% of that population. Determination of this mutation provides a basis for the development of a simple and non-invasive diagnostic test for the disease and the carrier state in this population and confirms biochemical data showing the importance of this gene in glucose homeostasis.
VI型糖原贮积病(GSD6)是一组导致肝肿大和低血糖且肝磷酸化酶活性降低的疾病。这些疾病的病程通常较轻,但明确诊断需要侵入性检查。我们分析了一个患有常染色体隐性遗传形式GSD6的门诺派家族,以确定分子缺陷并开发一种非侵入性诊断测试。使用位于肝糖原磷酸化酶基因(PYGL)两侧的遗传标记进行连锁分析,基于生化原因怀疑该基因是导致该疾病的原因。门诺派GSD6与PYGL基因座连锁,多点LOD评分为4.7。通过对基因组DNA进行测序来分析PYGL基因的突变。基因组DNA测序揭示了内含子13剪接供体的剪接位点异常。通过对RT-PCR产物进行测序来确认基因组突变,结果显示受影响者中PYGL mRNA存在异质性,缺失全部或部分外显子13。本研究首次证明PYGL基因突变可导致GSD6。估计该突变存在于3%的门诺派染色体上,该疾病影响该人群的0.1%。确定该突变可为开发针对该人群中该疾病及其携带者状态的简单非侵入性诊断测试提供依据,并证实了生化数据显示该基因在葡萄糖稳态中的重要性。